Home > Insider Trading > Filing (0001232524-15-000120)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615764	Iain Mcgill	Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2	Svp, Europe And Rest Of World	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2015-05-26	5,834	$46.83	30,530	No	4	M	Direct
Ordinary Shares	Acquisiton	2015-05-26	1,500	$59.13	32,030	No	4	M	Direct
Ordinary Shares	Disposition	2015-05-26	7,334	$179.48	24,696	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Non-Qualified Stock Option (right to buy)	Disposition	2015-05-26	5,834	$0.00	5,834	$46.83
Ordinary Shares	Non-Qualified Stock Option (right to buy)	Disposition	2015-05-26	1,500	$0.00	1,500	$59.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,500		2022-08-08	No	4	M	Direct
5,500		2023-03-04	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.17 to $179.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 9, 2015 to August 9, 2016.
Following the reported transaction, the remaining ordinary shares subject to this option vest in equal monthly installments from June 5, 2015 to March 5, 2017.